Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Enzalutamide”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT01981707
What this trial is testing

F-choline PET in Early Response Assessment for Castration Resistant Prostatic Cancer

Who this might be right for
Castration-resistant Prostate Cancer
University Hospital, Grenoble 12
Not applicableStudy completedNCT04290611
What this trial is testing

A Vigibase Pharmacovigilance Study of ENzalutamide Drug-induced neurotoxicitY

Who this might be right for
Prostate CancerNeuropathyEpilepsy+1 more
Groupe Hospitalier Pitie-Salpetriere 500,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT05011188
What this trial is testing

FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate CancerProstate Cancer
Rahul Aggarwal 44
Testing effectiveness (Phase 2)Ended earlyNCT02640534
What this trial is testing

Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone

Who this might be right for
Cancer of the ProstateProstate Cancer
Swiss Cancer Institute 169
Large-scale testing (Phase 3)Active Not RecruitingNCT04455750
What this trial is testing

A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more
Alliance for Clinical Trials in Oncology 61
Testing effectiveness (Phase 2)UnknownNCT02935205
What this trial is testing

Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate CarcinomaRecurrent Prostate CarcinomaStage IV Prostate Cancer
Mamta Parikh 38
Large-scale testing (Phase 3)Looking for participantsNCT06136650
What this trial is testing

Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (mCRPC)Prostatic Neoplasms
Merck Sharp & Dohme LLC 1,314
Early research (Phase 1)Study completedNCT01362374
What this trial is testing

Safety and Clinical Pharmacology of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Participants With Advanced Solid Tumors

Who this might be right for
Neoplasms
Genentech, Inc. 122
Large-scale testing (Phase 3)Active Not RecruitingNCT04821622
What this trial is testing

Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC

Who this might be right for
Prostate Cancer
Pfizer 599
Large-scale testing (Phase 3)Active Not RecruitingNCT06764485
What this trial is testing

Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Celgene 960
Large-scale testing (Phase 3)Study completedNCT02288247
What this trial is testing

Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking Enzalutamide Alone

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Astellas Pharma Europe Ltd. 688
Large-scale testing (Phase 3)Study completedNCT02987543
What this trial is testing

Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
AstraZeneca 387
Early research (Phase 1)Not Yet RecruitingNCT07683013
What this trial is testing

Safety, Tolerability, and Efficacy of CP-PCA07 in Combination With Enzalutamide in Patients With Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)
Hyundai Bioscience Co., Ltd. 18
Not applicableWithdrawnNCT04742972
What this trial is testing

Prostate PMSABR Study

Who this might be right for
Prostate Cancer
Darren Poon
Large-scale testing (Phase 3)Study completedNCT03834493
What this trial is testing

Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

Who this might be right for
Prostatic Neoplasms
Merck Sharp & Dohme LLC 1,244
Early research (Phase 1)Looking for participantsNCT07277270
What this trial is testing

GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 83
Testing effectiveness (Phase 2)Study completedNCT01302041
What this trial is testing

Test if Enzalutamide is Effective and Safe in Prostate Cancer Patients Who Have Never Had Hormone Therapy

Who this might be right for
Prostate Cancer
Astellas Pharma Inc 67
Not applicableStudy completedNCT02588001
What this trial is testing

Japanese Research for Patients With Non-metastatic Castration Resistant Prostate Cancer - Enzalutamide

Who this might be right for
Prostate Cancer
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 60
Testing effectiveness (Phase 2)Study completedNCT01974765
What this trial is testing

Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies

Who this might be right for
Advanced Epithelial OvarianRecurrent Epithelial OvarianFallopian Tube+1 more
Memorial Sloan Kettering Cancer Center 59
Early research (Phase 1)Study completedNCT01911728
What this trial is testing

Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates

Who this might be right for
Pharmacokinetics of MDV3100Castration Resistant Prostate Cancer (CRPC)
Astellas Pharma Europe B.V. 14
Next Page